Figure 3 : PLS-DA analysis of patient samples with moderate infection level for first two days with the control group and PLS-DA analysis of patient samples with severe infection level for first two days with the control group (S:severe, M: moderate, C:Control) a, partial Least Squares Discriminant Analysis score plot. Component 1: accuracy=0.983, (R2=0.821, Q2=0.739), component 2: accuracy=0.983, (R2=0.860, Q2=0.790), component 3: accuracy=0.983, (R2=0.954, Q2=0.829) b, Variable importance score plot in PLS-DA VIP Projection. c, partial Least Squares Discriminant Analysis score plot. Component 1: accuracy=0.950, (R2=0.857, Q2=0.702), component 2: accuracy=1, (R2=0,938, Q2=0.797), component 3: accuracy=1, (R2=0.982, Q2=0.824) d, Variable importance score plot in PLS-DA VIP Projection. e, corresponding compounds in detected increases on the spectra. f, corresponding compounds in detected increases on the spectra.